Sec. 705. Report on prospective ability to administer COVID–19 vaccines and other medical interventions to certain intelligence community personnel
696 words·~3 min read·
/bill/117/hr/5412/ih/section-705A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 180 days after the date of the enactment of this Act, the Director of National Intelligence and the Under Secretary of Defense for Intelligence and Security, in consultation with the elements of the intelligence community and relevant public health agencies of the United States, shall jointly develop and submit to the congressional intelligence committees a report on the prospective ability of the intelligence community to administer COVID–19 vaccines, and such other medical interventions as may be relevant in the case of a future covered national emergency, to covered personnel (particularly with respect to essential covered personnel and covered personnel deployed outside of the United States).
The report under subsection
(a)shall include an assessment of the following: The prospective ability of the elements of the intelligence community to administer COVID–19 vaccines (including subsequent booster shots for COVID–19), to covered personnel, and whether additional authorities or resources are necessary for, or may otherwise facilitate, such administration. The potential risks and benefits of granting the additional authorities or resources described in paragraph
(1)to the Director, the Under Secretary, or both. With respect to potential future covered national emergencies, including future outbreaks of an infectious pandemic disease or similar public health emergencies, the following: The ability of the intelligence community to ensure the timely administration of medical interventions to covered personnel during the covered national emergency. Whether additional authorities or resources are necessary to ensure, or may otherwise facilitate, such timely administration, including with respect to the ability of the Director or Under Secretary to provide an alternative means of access to covered personnel with reduced access to the interventions provided by the respective element. The potential risks and benefits of granting the additional authorities or resources described in subparagraph
(B)to the Director, the Under Secretary, or both. A summary of the findings of the survey under subsection (c). Not later than 120 days after the date of the enactment of this Act, and prior to submitting the report under subsection (a), the Director and the Under Secretary shall jointly conduct a survey to determine the process by which each element of the intelligence community has administered COVID–19 vaccines to covered personnel, to inform continued medical care relating to COVID–19 and future responses to covered national emergencies. Such survey shall address, with respect to each element, the following: The timeline of the element with respect to the administration of COVID–19 vaccines prior to the date of the enactment of this Act. The process by which the element determined when covered personnel would become eligible to receive the COVID–19 vaccine (including if certain categories of such personnel became eligible before others). A general approximation of the percentage of covered personnel of the element that received the COVID–19 vaccine from the element versus through an alternative means (such as a private sector entity, foreign government, State, or local government), particularly with respect to covered personnel deployed outside of the United States. Any challenges encountered by the element with respect to the administration of COVID–19 vaccines prior to the date of the enactment of this Act. Any other feedback determined relevant for purposes of the survey. In carrying out the report and survey requirements under this section, the Director, the Under Secretary, and the heads of the elements of the intelligence community shall ensure, to the extent practicable, the preservation of medical privacy and the anonymity of data. In this section: The term covered national emergency has the meaning given such term in section 303 of the Intelligence Authorization Act for Fiscal Year 2021 ( 50 U.S.C. 3316b ). The term covered personnel means personnel who are— employees of, or otherwise detailed or assigned to, an element of the intelligence community; and funded under the National Intelligence Program or the Military Intelligence Program. The term essential covered personnel means covered personnel deemed essential to— continuity of operations of the intelligence community; continuity of operations of the United States Government; or other purposes related to the national security of the United States. The term National Intelligence Program has the meaning given such term in section 3 of the National Security Act of 1947 ( 50 U.S.C. 3003 ).
Connectionstraces to 2
Citation graph
cites case law
Sec. 705
Report on prospective ability to administer COVID–19 vaccines and other medical interventions to certain intelligence community personnel
Cites 2Cited by 0 across 0 sources